Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000689227 | SCV000816868 | pathogenic | Niemann-Pick disease, type C1 | 2023-09-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function. ClinVar contains an entry for this variant (Variation ID: 568770). This missense change has been observed in individual(s) with Niemann-Pick disease type C1 (PMID: 19744920, 20718790, 27581084; Invitae). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1151 of the NPC1 protein (p.Ala1151Thr). |
Eurofins Ntd Llc |
RCV000734932 | SCV000863112 | likely pathogenic | not provided | 2018-08-30 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000734932 | SCV001740709 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000734932 | SCV001972122 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000689227 | SCV002095163 | likely pathogenic | Niemann-Pick disease, type C1 | 2020-10-27 | no assertion criteria provided | clinical testing |